A case of schizophrenia with congenital color vision deficiency: From the perspective of color universal design to promote medication adherence
Abstract Color‐blindness, or more accurately, color vision deficiency (CVD), which is the inability or decreased ability to distinguish different colors, is one of the commonest visual disorders. Patients with schizophrenia usually have multiple types of visual processing impairments, including colo...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-09-01
|
| Series: | Neuropsychopharmacology Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/npr2.12278 |
| _version_ | 1811301361491378176 |
|---|---|
| author | Kensuke Miyazaki Michiko Uchiyama Chieko Tsushima Kentarou Fujimoto |
| author_facet | Kensuke Miyazaki Michiko Uchiyama Chieko Tsushima Kentarou Fujimoto |
| author_sort | Kensuke Miyazaki |
| collection | DOAJ |
| description | Abstract Color‐blindness, or more accurately, color vision deficiency (CVD), which is the inability or decreased ability to distinguish different colors, is one of the commonest visual disorders. Patients with schizophrenia usually have multiple types of visual processing impairments, including color vision impairments. Here, we present a case of schizophrenia with congenital CVD. The patient was aware of his color deficiency since elementary school. We assessed his ability to distinguish medicines based on their color, including those that he had been previously prescribed. Although he could distinguish all of the tablets, he could not distinguish the color of the blister packs, specifically that of the bromazepam 2 mg pack (green) from the 1 mg pack (red). This case suggests that CVD patients might misunderstand the color of medications, which might lead to medication errors, or poor drug adherence. The color universal design principle should be considered when designing tablets and their blister packs, in order to improve medication adherence. |
| first_indexed | 2024-04-13T07:07:31Z |
| format | Article |
| id | doaj.art-2d16fcefdb1e49ee9b6e4afd4976f0c7 |
| institution | Directory Open Access Journal |
| issn | 2574-173X |
| language | English |
| last_indexed | 2024-04-13T07:07:31Z |
| publishDate | 2022-09-01 |
| publisher | Wiley |
| record_format | Article |
| series | Neuropsychopharmacology Reports |
| spelling | doaj.art-2d16fcefdb1e49ee9b6e4afd4976f0c72022-12-22T02:56:57ZengWileyNeuropsychopharmacology Reports2574-173X2022-09-0142338438610.1002/npr2.12278A case of schizophrenia with congenital color vision deficiency: From the perspective of color universal design to promote medication adherenceKensuke Miyazaki0Michiko Uchiyama1Chieko Tsushima2Kentarou Fujimoto3Department of Neuropsychiatry Hirosaki‐Aiseikai Hospital Hirosaki‐shi, Aomori JapanDepartment of Hospital Pharmacy Hirosaki‐Aiseikai Hospital Hirosaki‐shi, Aomori JapanDepartment of Nursing Hirosaki‐Aiseikai Hospital Hirosaki‐shi, Aomori JapanDepartment of Hospital Pharmacy Hirosaki‐Aiseikai Hospital Hirosaki‐shi, Aomori JapanAbstract Color‐blindness, or more accurately, color vision deficiency (CVD), which is the inability or decreased ability to distinguish different colors, is one of the commonest visual disorders. Patients with schizophrenia usually have multiple types of visual processing impairments, including color vision impairments. Here, we present a case of schizophrenia with congenital CVD. The patient was aware of his color deficiency since elementary school. We assessed his ability to distinguish medicines based on their color, including those that he had been previously prescribed. Although he could distinguish all of the tablets, he could not distinguish the color of the blister packs, specifically that of the bromazepam 2 mg pack (green) from the 1 mg pack (red). This case suggests that CVD patients might misunderstand the color of medications, which might lead to medication errors, or poor drug adherence. The color universal design principle should be considered when designing tablets and their blister packs, in order to improve medication adherence.https://doi.org/10.1002/npr2.12278color blindnesscolor universal designcolor vision deficiencymedication adherenceschizophrenia |
| spellingShingle | Kensuke Miyazaki Michiko Uchiyama Chieko Tsushima Kentarou Fujimoto A case of schizophrenia with congenital color vision deficiency: From the perspective of color universal design to promote medication adherence Neuropsychopharmacology Reports color blindness color universal design color vision deficiency medication adherence schizophrenia |
| title | A case of schizophrenia with congenital color vision deficiency: From the perspective of color universal design to promote medication adherence |
| title_full | A case of schizophrenia with congenital color vision deficiency: From the perspective of color universal design to promote medication adherence |
| title_fullStr | A case of schizophrenia with congenital color vision deficiency: From the perspective of color universal design to promote medication adherence |
| title_full_unstemmed | A case of schizophrenia with congenital color vision deficiency: From the perspective of color universal design to promote medication adherence |
| title_short | A case of schizophrenia with congenital color vision deficiency: From the perspective of color universal design to promote medication adherence |
| title_sort | case of schizophrenia with congenital color vision deficiency from the perspective of color universal design to promote medication adherence |
| topic | color blindness color universal design color vision deficiency medication adherence schizophrenia |
| url | https://doi.org/10.1002/npr2.12278 |
| work_keys_str_mv | AT kensukemiyazaki acaseofschizophreniawithcongenitalcolorvisiondeficiencyfromtheperspectiveofcoloruniversaldesigntopromotemedicationadherence AT michikouchiyama acaseofschizophreniawithcongenitalcolorvisiondeficiencyfromtheperspectiveofcoloruniversaldesigntopromotemedicationadherence AT chiekotsushima acaseofschizophreniawithcongenitalcolorvisiondeficiencyfromtheperspectiveofcoloruniversaldesigntopromotemedicationadherence AT kentaroufujimoto acaseofschizophreniawithcongenitalcolorvisiondeficiencyfromtheperspectiveofcoloruniversaldesigntopromotemedicationadherence AT kensukemiyazaki caseofschizophreniawithcongenitalcolorvisiondeficiencyfromtheperspectiveofcoloruniversaldesigntopromotemedicationadherence AT michikouchiyama caseofschizophreniawithcongenitalcolorvisiondeficiencyfromtheperspectiveofcoloruniversaldesigntopromotemedicationadherence AT chiekotsushima caseofschizophreniawithcongenitalcolorvisiondeficiencyfromtheperspectiveofcoloruniversaldesigntopromotemedicationadherence AT kentaroufujimoto caseofschizophreniawithcongenitalcolorvisiondeficiencyfromtheperspectiveofcoloruniversaldesigntopromotemedicationadherence |